Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor characterized by aggressive local invasion and a syndrome of platelet trapping known as Kasabach-Merritt phenomenon that, through deposition of platelet derived growth factors, may perpetuate the growth of the tumor. Although many cases of KHE are successfully treated with local control or low-intensity chemotherapy, some cases are often refractory even to aggressive treatment. Herein, we describe a patient with a refractory, recurrent KHE despite multiple attempts at local control and intensive chemotherapy, that ultimately was successfully treated with rationally designed and low-intensity combination therapy of sirolimus and aspirin.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000001046DOI Listing

Publication Analysis

Top Keywords

kaposiform hemangioendothelioma
8
sirolimus aspirin
8
local control
8
management refractory
4
refractory pediatric
4
pediatric kaposiform
4
hemangioendothelioma sirolimus
4
aspirin kaposiform
4
hemangioendothelioma khe
4
khe rare
4

Similar Publications

Background: Kaposiform hemangioendothelioma is a rare vascular tumor primarily occurring in infants and children. The most common sites for kaposiform hemangioendothelioma are extremities, with very few cases of abdominal kaposiform hemangioendothelioma reported in neonates. Making a diagnosis of Kaposiform hemangioendothelioma can be challenging when the patient presents with generalized symptoms such as bilious vomiting and constipation that can be attributed to other more common causes of intestinal obstruction.

View Article and Find Full Text PDF

Hemostasis and thrombosis risks and management in vascular anomalies.

Hematology Am Soc Hematol Educ Program

December 2024

Pediatric Hematology-Oncology, University of Arkansas for Medical Sciences, Little Rock, AR.

The role of the hematologist in the management of vascular anomalies is evolving. Several vascular tumors and malformations are associated with complex coagulation derangements. Kaposiform hemangioendothelioma or tufted angiomas may present with a consumptive coagulopathy known as the Kasabach-Merritt phenomenon (KMP).

View Article and Find Full Text PDF

Advances in vascular anomalies: refining classification in the molecular era.

Histopathology

December 2024

Department of Pathology, Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.

Article Synopsis
  • The understanding of vascular anomalies has progressed since the original classification by Mulliken and Glowacki, with current research focusing on distinguishing vascular tumors from malformations.
  • Recent advancements in molecular diagnostics have improved the identification and management of complex vascular lesions, including Kaposiform hemangioendothelioma and intramuscular fast-flow anomalies.
  • The review discusses the genetic mutations involved, particularly in the RAS/PI3K/mTOR pathways, and highlights new targeted treatments like PI3K and MEK inhibitors that can enhance patient outcomes.
View Article and Find Full Text PDF

Kaposiform hemangioendothelioma (KHE) is a rare neoplasm of the newborn, but has a very high mortality rate. In this study, we explore the application value of ultrasound radiomics in the differential diagnosis of KHE so as to provide reference for early diagnosis of KHE. We selected 194 cases of children with suspected KHE admitted to Henan Provincial People's Hospital from March 2016 to April 2024 for this retrospective analysis.

View Article and Find Full Text PDF

Kaposiform hemangioendothelioma (KHE) is a vascular neoplasm characterized by abnormal angiogenesis and lymphangiogenesis. Here, we present a case of a 19-month-old male with KHE of the right leg with bony involvement who was initially misdiagnosed with infantile hemangioma. Due to its heterogeneous presentation and frequent occurrence of comorbidities such as Kasabach-Merritt phenomenon, clinical and pathological correlation is essential for diagnosis of KHE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!